This review reports the results of application of short peptides in glioma therapy clinical trials, their rises and falls.
In this interview with Francesco Lo-coco we discussed a randomized clinical trial conducted with the drug Trisenox as well as, the genetic characterization, monitoring and treatment of hematologic tumors, particularly acute promyelocytic leukemia.
This article outlines how heat change can influence magnetic nanoparticles in cancer therapy, it covers the magnetic nanoparticle, thermal therapy, heat performance and future prospectives.
In this editorial, we will review emerging evidence for the relationship between sexual orientation, indoor tanning and melanoma and discuss implications for clinical practice, research and public health.
This editorial discusses the impact of the numer of melanocytic nevi (moles) and the risk of developing melanoma.
This article provides a immunotherapy perspective of Ipilimumab, a CTLA-4-targeted monoclonal antibody, reviewing drug mechanism, blockade, combination therapies and future prospectives.
This report outlines the clinically led development of UK-focused guidance to challenge psycho-oncology services to achieve and demonstrate their potential.
Primary research to evaluate whether Recursive Partitioning Analysis or Graded Prognostic Assessment is more useful to clinicians.
A commentry of brain tumors associated with Li-Fraumeni syndrome, followed by a case report of the development of a rare gliosarcoma in a Li-Fraumeni patient
A comprehensive review article of the avaliable therapeutic strategies developed against malignant gliomas based on ‘actively targeted’ nanoparticles, it discusses challenges, mechanisms, clinical studies and treatment options